Paul A Friedman
Director · 1 filing · Latest: Jun 9, 2026
Prelude Therapeutics Inc
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
MDGL | PAUL FRIEDMAN | — | Sep 28, 2026 | Proposed Sale | $516.56 | 50,000 | $25.8M | — | |
MDGL | PAUL FRIEDMAN | — | Dec 10, 2025 | Proposed Sale | $553.92 | 49,600 | $27.5M | — | |
MDGL | PAUL FRIEDMAN | — | Aug 13, 2025 | Proposed Sale | $359.00 | 129,172 | $46.4M | — | |
MDGL | PAUL FRIEDMAN | — | Aug 12, 2025 | Proposed Sale | $349.50 | 43,605 | $15.2M | — | |
MDGL | PAUL FRIEDMAN | — | Aug 11, 2025 | Proposed Sale | $345.73 | 3,203 | $1.1M | — | |
MDGL | PAUL FRIEDMAN | — | Jul 18, 2025 | Proposed Sale | $348.73 | 1,400 | $488.2K | — | |
MDGL | PAUL FRIEDMAN | — | Jul 17, 2025 | Proposed Sale | $344.97 | 2,700 | $931.4K | — | |
MDGL | PAUL FRIEDMAN | — | Jul 16, 2025 | Proposed Sale | $311.14 | 26,176 | $8.1M | — |